Sun Pharmaceutical stated that its subsidiaries Sun Pharmaceutical Industries (SPII) and Taro Pharmaceuticals USA (Taro) have ...

Sun Pharmaceutical Industries Ltd. has announced that its U.S. subsidiaries, Sun Pharmaceutical Industries Inc. and Taro ...

Under the agreement, Sun Pharmaceutical Industries, Inc. and Taro will make a combined payment of $200 million in exchange for a full release of all claims brought against them by the End Purchaser ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the incorporation of a subsidiary company, Sun Pharma (Hainan) ...

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...

Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation data boosted expectations of further rate cuts this year by the central ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...

India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for additional rate cuts this year from the central bank.The Nifty 50 finished 0 ...